Several clinical factors were shown to be confounders that influenced the association between actionable mutations and mutation burden, whereas smoking status, PET SUV‐max, and elevated CEA level were found to be independently and significantly associated with mutation burden in patients with resected NSCLC. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.